Japan identifies tissue-specific exosome marker candidates from blood

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), based in Japan, has successfully&...

March 22, 2022 | Tuesday | News
Korea shows AI tool as novel biomarker for immunotherapy response

Lunit, a South Korea-based startup has announced the publication of its study in the Journal of Clinical Oncology (JCO)....

March 18, 2022 | Friday | News
HitGen partners with Howard Hughes Medical Institute and Duke University

HitGen has entered into a research collaboration agreement with Howard Hughes Medical Institute ("HHMI") and Duke Univer...

March 18, 2022 | Friday | News
Lynk Pharmaceuticals and Simcere partner for novel JAK1 inhibitor LNK01001

Lynk Pharmaceuticals and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 ...

March 18, 2022 | Friday | News
Biological regenerative medicine solutions enter Middle East and Pakistan

European Wellness Biomedical Group (EWBG) has signed a Memorandum of Agreement (MOA) with Dubai-based AK Internatio...

March 15, 2022 | Tuesday | News
Emerging Trends in Biopharma Deal-Making

Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, ...

March 15, 2022 | Tuesday | News
Adlai Nortye appoints Dr. Victoria Demby as Sr. VP of Global Regulatory Affairs

Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies,...

March 15, 2022 | Tuesday | News
Chinese startup MediLink Therapeutics closes $70 M Series B financing

MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) has announced completion of a $70million Series B financing. Thi...

March 15, 2022 | Tuesday | News
South Korea lays focus on novel mRNA therapeutics

NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, has signed...

March 15, 2022 | Tuesday | News
Eucure Biopharma starts Phase I trial of YH002 (Anti-OX40 mAb)

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...

March 14, 2022 | Monday | News
Everest Medicines offers treatment for primary IgA nephropathy in South Korea

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...

March 14, 2022 | Monday | News
Impact Therapeutics announces completion of series D1 financing

IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...

March 14, 2022 | Monday | News
SOPHiA GENETICS HRD Solution makes way in Asia Pacific

SOPHiA GENETICS has announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aimi...

March 10, 2022 | Thursday | News
Singleron extends reach outside China, strengthens expertise in translational & clinical research

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...

March 8, 2022 | Tuesday | News
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers

To mark International HPV Awareness Day March 4th 2022, the International Papillomavirus Society (IPVS) has warmly ...

March 7, 2022 | Monday | News
AnchorDx appoints Dr. Marina Bibikova as Chief Scientific Officer

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...

March 7, 2022 | Monday | News
Anti-viral agent in Australian-developed nasal spray highly active against 'Omicron'

In a major development for its VIRALEZE™ antiviral nasal spray, Australia-based Starpharma has announced that its ...

March 4, 2022 | Friday | News
South Korea's Aston Sci. raises $22.7 M in Series C

South Korea-based startup Aston Sci. has announced the completion of the Series C funding at a scale of $22.7 milli...

March 4, 2022 | Friday | News
Asian real-world data critical for global life science research

Swiss firm BC Platforms (BCP), has announced expansion of its R&D operations in Singapore, which spearhead...

March 3, 2022 | Thursday | News
New research in Australia aims to end refrigeration of vaccines

Researchers at Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisation (...

February 23, 2022 | Wednesday | News
Japan uses network models to help understand spread of new COVID-19 variants

Researchers from Tokyo Metropolitan University in Japan have performed numerical simulations based on network theory whi...

February 22, 2022 | Tuesday | News
India designs new strategy for development of drug molecules

An interdisciplinary research group led by Prof V. Haridas from the Indian Institute of Technology (IIT) Delhi’s C...

February 21, 2022 | Monday | News
Chief Minister Bhupendra Patel announces New Biotechnology Policy of Gujarat

Chief Minister Bhupendra Patel has unveiled the new ‘Gujarat Biotechnology Policy 2022-27’ with a commitment...

February 18, 2022 | Friday | News
Singapore researchers discover unique lysin against multidrug-resistant bacteria

Caption: SMART AMR researchers Boon Chong Goh (left) and Joash Chu (right) evaluate the effectiveness of lysins aga...

February 17, 2022 | Thursday | News
Japan-based Fujifilm introduces life sciences strategic investment fund

FUJIFILM Corporation has announced the launch of its life sciences strategic investment fund managed by the Life Science...

February 14, 2022 | Monday | News